Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AUXILIUM PHARMACEUTICALS INC | 252,496 | reported | 23 Jun 2006 | tx 6+241,500−4,344 |
| Recro Pharma, Inc. | 38,012 | reported | 20 Apr 2021 | tx 58+2,290,446−653,011 |
| Alkermes plc. | 25,000 | reported | 28 May 2014 | tx 42+446,000−296,000 |
| TETRAPHASE PHARMACEUTICALS INC | 16,500 | reported | 10 Jun 2019 | tx 5+71,500 |
| Baudax Bio, Inc. | 2,427 | reported | 15 Dec 2022 | tx 15+1,468,177−115,857 |
| ALKERMES INC | 0 | reported | 16 Sept 2011 | tx 18+140,000−198,000 |
| MAP Pharmaceuticals, Inc. | 0 | reported | 01 Mar 2013 | tx 34+85,754−134,008 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Dec 2022 | PURCHASE | Baudax Bio, Inc. | 1,200 | 2.55 USD | first after silence |
| 15 Jun 2022 | GRANT_AWARD | Baudax Bio, Inc. | 39,473 | 0.00 USD | |
| 15 Dec 2021 | TAX_WITHHOLDING | Baudax Bio, Inc. | 18,636 | 0.31 USD | |
| 22 Dec 2021 | GRANT_AWARD | Baudax Bio, Inc. | 821,168 | 0.00 USD | deriv |
| 05 Dec 2021 | TAX_WITHHOLDING | Baudax Bio, Inc. | 9,155 | 0.35 USD | |
| 22 Sept 2021 | PURCHASE | Baudax Bio, Inc. | 8,200 | 0.59 USD | |
| 07 May 2021 | PURCHASE | Baudax Bio, Inc. | 6,000 | 0.83 USD | first after silence |
| 20 Apr 2021 | GRANT_AWARD | Recro Pharma, Inc. | 26,923 | 0.00 USD | |
| 20 Apr 2021 | GRANT_AWARD | Recro Pharma, Inc. | 38,012 | 0.00 USD | deriv |
| 13 Apr 2021 | GRANT_AWARD | Recro Pharma, Inc. | 20,000 | 0.00 USD | deriv |
| 20 Jan 2021 | GRANT_AWARD | Baudax Bio, Inc. | 65,435 | 0.00 USD | |
| 18 Jan 2021 | EXERCISE | Recro Pharma, Inc. | 5,000 | — | |
| 18 Jan 2021 | TAX_WITHHOLDING | Recro Pharma, Inc. | 6,816 | 3.03 USD | |
| 18 Jan 2021 | EXERCISE | Recro Pharma, Inc. | 5,000 | 0.00 USD | deriv |
| 02 Jan 2021 | TAX_WITHHOLDING | Recro Pharma, Inc. | 5,599 | 3.09 USD | |
| 05 Dec 2020 | TAX_WITHHOLDING | Recro Pharma, Inc. | 34,128 | 2.30 USD | |
| 05 Dec 2020 | TAX_WITHHOLDING | Baudax Bio, Inc. | 11,732 | 1.14 USD | |
| 05 Dec 2020 | TAX_WITHHOLDING | Baudax Bio, Inc. | 71,283 | 1.14 USD | |
| 17 Apr 2020 | SALE | Recro Pharma, Inc. | 80,000 | 8.22 USD | |
| 27 Jan 2020 | EXERCISE | Baudax Bio, Inc. | 19,070 | — | |
| 27 Jan 2020 | TAX_WITHHOLDING | Baudax Bio, Inc. | 5,051 | 8.51 USD | |
| 18 Jan 2020 | TAX_WITHHOLDING | Recro Pharma, Inc. | 5,552 | 16.38 USD | |
| 18 Jan 2020 | EXERCISE | Recro Pharma, Inc. | 5,000 | — | |
| 18 Jan 2020 | EXERCISE | Recro Pharma, Inc. | 5,000 | 0.00 USD | deriv |
| 02 Jan 2020 | TAX_WITHHOLDING | Recro Pharma, Inc. | 4,945 | 17.53 USD |
4 purchases reported after at least 12 months of silence — most recent on 15 Dec 2022.